CLAIRITY™ XCELL is an advanced cell analysis software designed for automated, non-invasive cell characterization in brightfield and phase contrast microscopy. Purpose-built for pharmaceutical research, biologics, and regenerative medicine, it delivers high-throughput insights across viability, morphology, apoptosis, and differentiation studies.
The system integrates seamlessly with Olympus microscopes and uses AI-trained models to identify total cells, live/dead populations, budding patterns, and developmental stages, removing manual inconsistencies and enabling rapid, reproducible results. From stem cell behavior to cell viability analysis tool needs, CLAIRITY™ XCELL supports both stained and stain-free workflows with e-signature-enabled, regulatory-ready outputs.
Cell populations often display inconsistent morphology across samples. CLAIRITY™ XCELL uses adaptive segmentation and machine learning models trained on diverse shapes and sizes to deliver accurate cell classification and counts.
Manual counting fails in clustered regions, impacting accuracy. CLAIRITY™ XCELL isolates individual cells using advanced contour mapping and watershed segmentation for precise quantification.
Viability analysis in sensitive cultures can’t rely on toxic dyes. CLAIRITY™ XCELL distinguishes viable from non-viable cells using contrast and morphology-based AI, while also supporting Trypan Blue and AO/PI when required.
Visual tracking of stem or cancer cell differentiation is prone to subjectivity. CLAIRITY™ XCELL classifies developmental stages using nucleus-to-cytoplasm ratios, granularity, and shape evolution patterns.
Manual annotation and analysis delay decision-making. CLAIRITY™ XCELL processes large datasets in minutes, generates automated reports, and enables batch-wise analysis for high-throughput environments.
